FDA Recalls BC and Goody's Powders Due to Improper Storage Conditions
Family Dollar Stores is recalling BC Powder and Goody's Powder products due to improper storage temperature conditions. The affected products were distributed nationwide from April 30 through June 10, 2022.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for manufacturing deviations affecting storage conditions. No illnesses or injuries reported in source; risk is precautionary based on CGMP violations rather than confirmed harm.
Plain-English summary
Family Dollar Stores is recalling BC Powder and Goody's Powder products. The recalled items include BC Powder 50 CT (SKU 901588), BC Powder 18 CT (SKU 913228), and Goody's Powder 50 CT (SKU 901589).
The recall was issued due to current good manufacturing practice (CGMP) deviations. Specifically, the products were held outside appropriate storage temperature conditions.
The affected products were distributed to Family Dollar Stores nationwide between April 30, 2022 and June 10, 2022. The recalling firm is Family Dollar Stores, LLC.
The recalled product
- Product
- BC POWDER 50 CT SKU 901588 BC POWDER 18 CT SKU 913228 GOODYS POWDER 50 CT SKU 901589 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs: 901588
- 913228
- 901589
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27